PA8583301A1 - Nuevos compuestos de imidazol como inhibidores del factor de crecimiento transformante (tgf) - Google Patents
Nuevos compuestos de imidazol como inhibidores del factor de crecimiento transformante (tgf)Info
- Publication number
- PA8583301A1 PA8583301A1 PA20038583301A PA8583301A PA8583301A1 PA 8583301 A1 PA8583301 A1 PA 8583301A1 PA 20038583301 A PA20038583301 A PA 20038583301A PA 8583301 A PA8583301 A PA 8583301A PA 8583301 A1 PA8583301 A1 PA 8583301A1
- Authority
- PA
- Panama
- Prior art keywords
- tgf
- growth factor
- transforming growth
- inhibitors
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Abstract
SE DESCRIBEN NUEVOS COMPUESTOS DE IMIDAZOL, INCLUYENDO SUS DERIVADOS INTERMEDIOS PARA SU PREPARACION, COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN Y SU USO MEDICINAL. LOS COMPUESTOS DE LA PRESENTE INVENCION SON INHIBIDORES POTENTES DE RUTA DE SEÑALIZACION DEL FACTOR DEL CRECIMIENTO TRANSFORMANTE ("TGF)-ß. SON DE UTILIDAD EN EL TRATAMIENTO DE DIVERSOS ESTADOS DE ENFERMEDAD RELACIONADOS CON TGF INCLUYENDO POR EJEMPLO CANCER Y ENFERMEDADES FIBROTICAS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41189402P | 2002-09-18 | 2002-09-18 | |
US48452203P | 2003-07-02 | 2003-07-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
PA8583301A1 true PA8583301A1 (es) | 2004-09-16 |
Family
ID=32033577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PA20038583301A PA8583301A1 (es) | 2002-09-18 | 2003-09-17 | Nuevos compuestos de imidazol como inhibidores del factor de crecimiento transformante (tgf) |
Country Status (28)
Country | Link |
---|---|
US (2) | US7153872B2 (es) |
EP (1) | EP1542990B1 (es) |
JP (1) | JP4547271B2 (es) |
KR (1) | KR20050057392A (es) |
CN (1) | CN1681805A (es) |
AP (1) | AP2005003264A0 (es) |
AR (1) | AR041274A1 (es) |
AT (1) | ATE433968T1 (es) |
AU (1) | AU2003263404A1 (es) |
BR (1) | BR0314372A (es) |
CA (1) | CA2498047C (es) |
CO (1) | CO5550453A2 (es) |
DE (1) | DE60328028D1 (es) |
EA (1) | EA200500378A1 (es) |
EC (1) | ECSP055680A (es) |
ES (1) | ES2325687T3 (es) |
HR (1) | HRP20050252A2 (es) |
IS (1) | IS7712A (es) |
MA (1) | MA27441A1 (es) |
MX (1) | MXPA05002981A (es) |
NO (1) | NO20051008L (es) |
OA (1) | OA12928A (es) |
PA (1) | PA8583301A1 (es) |
PE (1) | PE20050072A1 (es) |
PL (1) | PL375980A1 (es) |
TW (1) | TW200404793A (es) |
UY (1) | UY27982A1 (es) |
WO (1) | WO2004026859A1 (es) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR039241A1 (es) * | 2002-04-04 | 2005-02-16 | Biogen Inc | Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos |
UA80295C2 (en) * | 2002-09-06 | 2007-09-10 | Biogen Inc | Pyrazolopyridines and using the same |
AP2005003264A0 (en) * | 2002-09-18 | 2005-03-31 | Pfizer Prod Inc | Novel imidazole compounds as transforming growth factor (TGD) inhibitors. |
AU2003259475A1 (en) * | 2002-09-18 | 2004-04-08 | Pfizer Products Inc. | Pyrazole derivatives as transforming growth factor (TGF) inhibitors |
KR20050057415A (ko) | 2002-09-18 | 2005-06-16 | 화이자 프로덕츠 인코포레이티드 | 전환성장인자(tgf) 억제제로서의 신규한 싸이아졸 및 옥사졸 화합물 |
PA8595001A1 (es) * | 2003-03-04 | 2004-09-28 | Pfizer Prod Inc | Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transforante (tgf) |
US20080319012A1 (en) * | 2004-04-21 | 2008-12-25 | In2Gen Co., Ltd. | 2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors |
KR100749566B1 (ko) | 2004-04-21 | 2007-08-16 | 이화여자대학교 산학협력단 | Alk5 및/또는 alk4 억제제로 유효한 2-피리딜이치환된 이미다졸 유도체 |
EP1765789B1 (en) * | 2004-06-18 | 2013-02-27 | Novartis AG | N-(1-(1-benzyl-4-phenyl-1h-imidazol-2-yl)-2,2-dimethylpropyl)benzamide derivatives and related compounds as kinesin spindle protein (ksp) inhibitors for the treatment of cancer |
CA2578630A1 (en) * | 2004-08-31 | 2006-03-09 | Wen-Cherng Lee | Pyrimidinylimidazoles as tgf-beta inhibitors |
EP1798229A4 (en) * | 2004-09-07 | 2009-07-29 | Sankyo Co | SUBSTITUTED BIPHENYL DERIVATIVE |
PE20070335A1 (es) * | 2005-08-30 | 2007-04-21 | Novartis Ag | Benzimidazoles sustituidos y metodos para su preparacion |
CN101330914A (zh) * | 2005-12-16 | 2008-12-24 | 爱尔康公司 | 使用alk5调节剂控制眼内压 |
CN1990473B (zh) * | 2005-12-30 | 2013-07-10 | 中国人民解放军军事医学科学院毒物药物研究所 | 三取代1h-咪唑类化合物、其制备方法、药物组合物及其制药用途 |
WO2008094556A2 (en) * | 2007-01-30 | 2008-08-07 | Biogen Idec Ma Inc. | Imidazolone compounds as tgf-beta family type i receptors, alk5 and/or alk4 antagonists |
JP2010529031A (ja) * | 2007-05-29 | 2010-08-26 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | Pi3キナーゼ阻害剤としてのナフチリジン誘導体 |
WO2009047163A1 (en) * | 2007-10-10 | 2009-04-16 | F. Hoffmann-La Roche Ag | Methods of treating inflammatory diseases |
US8865732B2 (en) | 2008-03-21 | 2014-10-21 | Novartis Ag | Heterocyclic compounds and uses thereof |
BRPI0908906A2 (pt) * | 2008-03-21 | 2019-09-24 | Novartis Ag | compostos heterocíclicos e usos dos mesmos |
US8324241B2 (en) | 2008-04-11 | 2012-12-04 | Bristol-Myers Squibb Company | Triazolo compounds useful as DGAT1 inhibitors |
US8394823B2 (en) | 2008-04-11 | 2013-03-12 | Bristol-Myers Squibb Company | Triazolopyridine compounds useful as DGAT1 inhibitors |
WO2009155388A1 (en) | 2008-06-20 | 2009-12-23 | Bristol-Myers Squibb Company | Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors |
AU2010264698C1 (en) | 2009-06-26 | 2013-05-16 | Novartis Ag | 1, 3-disubstituted imidazolidin-2-one derivatives as inhibitors of CYP 17 |
DE102009043260A1 (de) | 2009-09-28 | 2011-04-28 | Merck Patent Gmbh | Pyridinyl-imidazolonderivate |
DE102009049679A1 (de) | 2009-10-19 | 2011-04-21 | Merck Patent Gmbh | Pyrazolopyrimidinderivate |
USRE47141E1 (en) | 2010-06-29 | 2018-11-27 | EWHA University—Industry Collaboration Foundation | Methods of treating fibrosis, cancer and vascular injuries |
US8080568B1 (en) * | 2010-06-29 | 2011-12-20 | Ewha University - Industry Collaboration Foundation | 2-pyridyl substituted imidazoles as therapeutic ALK5 and/or ALK4 inhibitors |
DE102010049595A1 (de) | 2010-10-26 | 2012-04-26 | Merck Patent Gmbh | Chinazolinderivate |
US9242969B2 (en) | 2013-03-14 | 2016-01-26 | Novartis Ag | Biaryl amide compounds as kinase inhibitors |
ES2813875T3 (es) | 2014-01-01 | 2021-03-25 | Medivation Tech Llc | Compuestos y procedimientos de uso |
UY36294A (es) | 2014-09-12 | 2016-04-29 | Novartis Ag | Compuestos y composiciones como inhibidores de quinasa |
US10961239B2 (en) | 2017-01-05 | 2021-03-30 | Bristol-Myers Squibb Company | TGF beta receptor antagonists |
AU2019396360A1 (en) | 2018-12-11 | 2021-05-27 | Theravance Biopharma R&D Ip, Llc | Naphthyridine and quinoline derivatives useful as ALK5 inhibitors |
EP4061809A1 (en) | 2019-11-22 | 2022-09-28 | Theravance Biopharma R&D IP, LLC | Substituted 1,5-naphthyridines or quinolines as alk5 inhibitors |
KR102539660B1 (ko) | 2020-08-20 | 2023-06-02 | 가천대학교 산학협력단 | 베타-폴리비닐리덴 플루오라이드 코팅층이 형성된 아연 음극 및 상기 음극을 포함하는 수계 아연 이온 전지 |
KR20220031386A (ko) | 2020-09-04 | 2022-03-11 | 고려대학교 세종산학협력단 | 전기화학적 및 광전기화학적 수소 생산용 황화니켈 나노결정 촉매 및 이의 제조방법 |
US20230089180A1 (en) * | 2021-08-13 | 2023-03-23 | Bisichem Co., Ltd. | Fused ring heteroaryl compounds and use thereof |
CN115466260B (zh) * | 2022-09-06 | 2023-10-13 | 延边大学 | 含氨基酸结构的咪唑和噻唑类衍生物及其制备方法和应用 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3707475A (en) | 1970-11-16 | 1972-12-26 | Pfizer | Antiinflammatory imidazoles |
IL83467A0 (en) * | 1986-08-15 | 1988-01-31 | Fujisawa Pharmaceutical Co | Imidazole derivatives,processes for their preparation and pharmaceutical compositions containing the same |
US5656644A (en) * | 1994-07-20 | 1997-08-12 | Smithkline Beecham Corporation | Pyridyl imidazoles |
US6087381A (en) | 1997-05-22 | 2000-07-11 | G. D. Searle & Company | Pyrazole derivatives as p38 kinase inhibitors |
US6514977B1 (en) | 1997-05-22 | 2003-02-04 | G.D. Searle & Company | Substituted pyrazoles as p38 kinase inhibitors |
IL132736A0 (en) | 1997-05-22 | 2001-03-19 | Searle & Co | 3(5)-Heteroaryl substituted pyrazoles as p38 kinase inhibitors |
ES2187473T3 (es) * | 1999-04-09 | 2003-06-16 | Smithkline Beecham Corp | Triarylimidazoles. |
AR029803A1 (es) * | 2000-02-21 | 2003-07-16 | Smithkline Beecham Plc | Imidazoles sustituidos con piridilo y composiciones farmaceuticas que las comprenden |
GB0007405D0 (en) * | 2000-03-27 | 2000-05-17 | Smithkline Beecham Corp | Compounds |
PE20020506A1 (es) | 2000-08-22 | 2002-07-09 | Glaxo Group Ltd | Derivados de pirazol fusionados como inhibidores de la proteina cinasa |
GB0027987D0 (en) * | 2000-11-16 | 2001-01-03 | Smithkline Beecham Plc | Compounds |
EP1349851A4 (en) | 2000-11-16 | 2004-09-08 | Smithkline Beecham Corp | COMPOUNDS |
GB0100762D0 (en) | 2001-01-11 | 2001-02-21 | Smithkline Beecham Plc | Novel use |
WO2002066462A1 (en) | 2001-02-02 | 2002-08-29 | Glaxo Group Limited | Pyrazole derivatives against tgf overexpression |
GB0102672D0 (en) | 2001-02-02 | 2001-03-21 | Glaxo Group Ltd | Compounds |
JP2004521901A (ja) | 2001-02-02 | 2004-07-22 | グラクソ グループ リミテッド | Tgf阻害剤としてのピラゾール |
CA2440211A1 (en) * | 2001-03-09 | 2002-09-19 | Pfizer Products Inc. | Benzimidazole anti-inflammatory compounds |
AR039241A1 (es) * | 2002-04-04 | 2005-02-16 | Biogen Inc | Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos |
JP2005539000A (ja) | 2002-07-31 | 2005-12-22 | スミスクライン・ビーチャム・コーポレイション | Alk5阻害剤としての2−フェニルピリジン−4−イル誘導体 |
AP2005003264A0 (en) | 2002-09-18 | 2005-03-31 | Pfizer Prod Inc | Novel imidazole compounds as transforming growth factor (TGD) inhibitors. |
KR20050057415A (ko) | 2002-09-18 | 2005-06-16 | 화이자 프로덕츠 인코포레이티드 | 전환성장인자(tgf) 억제제로서의 신규한 싸이아졸 및 옥사졸 화합물 |
PL375973A1 (en) | 2002-09-18 | 2005-12-12 | Pfizer Products Inc. | Novel isothiazole and isoxazole compounds as transforming growth factor (tgf) inhibitors |
CA2497971A1 (en) | 2002-09-18 | 2004-04-01 | Pfizer Products Inc. | Triazole derivatives as transforming growth factor (tgf) inhibitors |
AU2003259475A1 (en) | 2002-09-18 | 2004-04-08 | Pfizer Products Inc. | Pyrazole derivatives as transforming growth factor (TGF) inhibitors |
PA8595001A1 (es) | 2003-03-04 | 2004-09-28 | Pfizer Prod Inc | Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transforante (tgf) |
-
2003
- 2003-09-08 AP AP2005003264A patent/AP2005003264A0/xx unknown
- 2003-09-08 PL PL03375980A patent/PL375980A1/xx not_active Application Discontinuation
- 2003-09-08 OA OA1200500077A patent/OA12928A/en unknown
- 2003-09-08 EA EA200500378A patent/EA200500378A1/ru unknown
- 2003-09-08 KR KR1020057004570A patent/KR20050057392A/ko not_active Application Discontinuation
- 2003-09-08 CN CNA038221608A patent/CN1681805A/zh active Pending
- 2003-09-08 MX MXPA05002981A patent/MXPA05002981A/es active IP Right Grant
- 2003-09-08 BR BR0314372-4A patent/BR0314372A/pt not_active IP Right Cessation
- 2003-09-08 AU AU2003263404A patent/AU2003263404A1/en not_active Abandoned
- 2003-09-08 EP EP03797429A patent/EP1542990B1/en not_active Expired - Lifetime
- 2003-09-08 CA CA002498047A patent/CA2498047C/en not_active Expired - Fee Related
- 2003-09-08 WO PCT/IB2003/003833 patent/WO2004026859A1/en active Application Filing
- 2003-09-08 AT AT03797429T patent/ATE433968T1/de not_active IP Right Cessation
- 2003-09-08 ES ES03797429T patent/ES2325687T3/es not_active Expired - Lifetime
- 2003-09-08 DE DE60328028T patent/DE60328028D1/de not_active Expired - Lifetime
- 2003-09-08 JP JP2004568901A patent/JP4547271B2/ja not_active Expired - Fee Related
- 2003-09-16 PE PE2003000942A patent/PE20050072A1/es not_active Application Discontinuation
- 2003-09-16 AR ARP030103358A patent/AR041274A1/es unknown
- 2003-09-16 UY UY27982A patent/UY27982A1/es not_active Application Discontinuation
- 2003-09-17 US US10/666,192 patent/US7153872B2/en not_active Expired - Fee Related
- 2003-09-17 TW TW092125609A patent/TW200404793A/zh unknown
- 2003-09-17 PA PA20038583301A patent/PA8583301A1/es unknown
-
2005
- 2005-02-24 IS IS7712A patent/IS7712A/is unknown
- 2005-02-24 NO NO20051008A patent/NO20051008L/no unknown
- 2005-03-17 CO CO05024820A patent/CO5550453A2/es not_active Application Discontinuation
- 2005-03-17 HR HR20050252A patent/HRP20050252A2/hr not_active Application Discontinuation
- 2005-03-17 EC EC2005005680A patent/ECSP055680A/es unknown
- 2005-03-18 MA MA28155A patent/MA27441A1/fr unknown
-
2006
- 2006-11-10 US US11/558,624 patent/US7635702B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20040106608A1 (en) | 2004-06-03 |
EP1542990A1 (en) | 2005-06-22 |
OA12928A (en) | 2006-10-13 |
ECSP055680A (es) | 2005-05-30 |
HRP20050252A2 (en) | 2005-10-31 |
MA27441A1 (fr) | 2005-07-01 |
MXPA05002981A (es) | 2005-06-22 |
PE20050072A1 (es) | 2005-03-01 |
US7153872B2 (en) | 2006-12-26 |
US7635702B2 (en) | 2009-12-22 |
ATE433968T1 (de) | 2009-07-15 |
EA200500378A1 (ru) | 2005-08-25 |
DE60328028D1 (de) | 2009-07-30 |
JP4547271B2 (ja) | 2010-09-22 |
CO5550453A2 (es) | 2005-08-31 |
IS7712A (is) | 2005-02-24 |
CA2498047A1 (en) | 2004-04-01 |
TW200404793A (en) | 2004-04-01 |
KR20050057392A (ko) | 2005-06-16 |
BR0314372A (pt) | 2005-07-19 |
PL375980A1 (en) | 2005-12-12 |
JP2006502237A (ja) | 2006-01-19 |
NO20051008L (no) | 2005-06-07 |
AU2003263404A1 (en) | 2004-04-08 |
EP1542990B1 (en) | 2009-06-17 |
US20070088037A1 (en) | 2007-04-19 |
CA2498047C (en) | 2009-05-19 |
AP2005003264A0 (en) | 2005-03-31 |
WO2004026859A1 (en) | 2004-04-01 |
CN1681805A (zh) | 2005-10-12 |
AR041274A1 (es) | 2005-05-11 |
UY27982A1 (es) | 2004-04-30 |
ES2325687T3 (es) | 2009-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PA8583301A1 (es) | Nuevos compuestos de imidazol como inhibidores del factor de crecimiento transformante (tgf) | |
PA8583401A1 (es) | Nuevos compuestos de triazol como inhibidores del factor de crecimiento transformante (tgf) | |
ECSP055679A (es) | Derivados de pirazol como inhibidores del factor del crecimiento transformante (tgf) | |
PA8582701A1 (es) | Nuevos compuestos de oxazol y tiazol como inhibidores del factor de crecimiento transformador (tgf) | |
PA8583101A1 (es) | Nuevos compuestos de isotiazol e isoxazol como inhibidores del factor de crecimiento transformador (tgf) | |
UY28214A1 (es) | Nuevos compuestos heteroaromáticos condensados que son inhibidores del factor de crecimiento transformante (tgf) | |
AR021844A1 (es) | Derivados de propanolamina aril-sustituidos, procedimientos para su preparacion, medicamentos que contienen estos compuestos y su utilizacion | |
PA8592301A1 (es) | Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos | |
BRPI0408251A (pt) | compostos de pirazina como inibidores do fator de crescimento transformante (tgf) | |
GT200000014A (es) | Derivados de quinolin - 2 - ona sustituidos con heteroarilo utiles como agentes anticancerigenos. | |
ECSP055609A (es) | "Uso de inhibidores de la IkB-quinasa para el tratamiento del dolor" | |
UY27891A1 (es) | Nuevos derivados de glicosido de tiofeno, procedimientos para la preparación de los mismos, medicamentos que contienen estos compuestos, y el uso de los mismos. | |
UY29182A1 (es) | "derivados de bencenosulfonamidas sustituídas, composiciones que las contienen, procedimientos de preparación y aplicaciones" | |
AR023423A1 (es) | Derivados de adamantano, procedimientos para su preparacion, composicion farmaceutica, procedimiento para la preparacion de la composicion farmaceutica, yuso de dichos derivados para la manufactura de medicamentos | |
AR048912A1 (es) | Inmunoglobulinas anti-nogo | |
GT200600199A (es) | Diarilsulfonas sulfonamidas y su uso | |
CY1110600T1 (el) | Αναλογα της βιταμινης d | |
AR018201A1 (es) | Compuesto de mesilato de n-(3-etinilfenil)-6,7-bis-(2-metoxietoxi)-4-quinazolinamina, composiciones que los contienen y su uso de dichos compuestos para la preparacion de medicamentos. | |
AR021843A1 (es) | Derivados de propanolamina sustituidos con heterociclos, procedimiento para su preparacion, y su utilizacion. | |
ATE302203T1 (de) | Pyrazolopyrimidin- und pyrazolotriazinderivate und diese enthaltende pharmazeutische zubereitungen | |
UY27372A1 (es) | Derivados de bencimidazol 1-aril-2-n, s u o-sustituidos, su uso para la obtención de medicamentos y preparados farmacéuticos que contienen estos derivados | |
UY26498A1 (es) | Pirroles sustituidos | |
CR7749A (es) | Nuevos compuestos de imidazol como inhibidores del factor de crecimiento transformante (tgf) | |
CR7748A (es) | Nuevos compuestos de pirazol como inhibidores del factor de crecimiento transformante (tgf) | |
DOP2003000713A (es) | Nuevos compuestos de pirarol como inhibidores delfactor de crecimiento transformante (tgf) |